Arcara Jeffrey 4
4 · Corvus Pharmaceuticals, Inc. · Filed Dec 8, 2025
Insider Transaction Report
Form 4
Arcara Jeffrey
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-12-04+100,000→ 100,000 totalExercise: $8.81Exp: 2035-12-04→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to 1/36th of the shares subject to the option in successive, equal monthly installments measured from December 4, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.